By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Senju Pharmaceutical Co., Ltd. 

2-5-8 Hiranomachi, Chuo-ku

Osaka    540  Japan
Phone: 81-0-6-2012512 Fax: ++81-0-6-2260406



Company News
InSite Vision (ISV) And Senju Pharmaceutical Co., Ltd. Announce Collaboration To Develop And Commercialize Azithromycin Ophthalmic Solution Using Durasite® In Japan 6/10/2014 10:03:16 AM
Sirion Therapeutics Acquires U.S. License To Develop New Treatment For Eye Disease 6/22/2006 1:48:40 PM
ISTA Pharmaceuticals, Inc. (ISTA) Expands Product Pipeline With Two Licensing Agreements For Exclusive North American Rights To Investigational Glaucoma Treatments; ISTA To Pay Approximately $8 Million 6/19/2006 11:41:49 AM
ISTA Pharmaceuticals, Inc. (ISTA) Files IND For Phase IIb Trial Of Ecabet Sodium10/19/2005 5:13:05 PM
ISTA Pharmaceuticals, Inc. (ISTA) Announces Xibrom Phase III Data To Be Presented At The 2005 American Society of Cataract & Refractive Surgery Symposium & Congress10/19/2005 5:12:43 PM
ISTA Pharmaceuticals, Inc. (ISTA) To Host Conference Call10/19/2005 5:12:14 PM
ISTA Pharmaceuticals, Inc. (ISTA) Licenses Exclusive U.S. Rights To Late-Stage Prescription Product For Dry Eye10/19/2005 5:12:14 PM
Allergan Inc. (AGN) And Senju Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement To Develop And Market LUMIGAN-R- In Japan10/19/2005 5:11:29 PM
Dainippon Pharmaceutical To Distribute Senju Pharmaceutical Co., Ltd.'s Animal Drugs10/19/2005 5:10:52 PM